\-\ Texto\\:\\ \ \(0\)\
\-\ chest\\ ct\\ demonstrates\\ right\\ apical\\ lung\\ mass\\ with\\ multiple\\ pulmonary\\ nodules\\ and\\ enlarged\\ subcarinal\\ and\\ paratracheal\\ lymph\\ nodes\\.\ \(0\)\
\-\ aggressive\\ chemotherapy\\ and\\ radiation\\ therapy\\ were\\ continued\\,\\ however\\ the\\ patient\\ succumbed\\ to\\ his\\ disease\\ 4\\ weeks\\ after\\ the\\ bone\\ scan\\ was\\ performed\\.\ \(0\)\
\-\ a\\ 99mtechnetium\\ methylene\\ diphosphonate\\ bone\\ scan\\ demonstrates\\ bilateral\\ upper\\ and\\ lower\\ extremity\\ periosteal\\ accumulation\\ of\\ bone\\ tracer\\.\ \(0\)\
\-\ hypertrophic\\ pulmonary\\ osteoarthropathy\\ \\(hpo\\)\ \(0\)\
\-\ metastatic\\ vs\\.\\ metabolic\\ bone\\ disease\\ \\(e\\.g\\.\\ paget\\â\\€\\™s\\ disease\\,\\ thyroid\\ acropachy\\,\\ acromegaly\\,\\ fibrous\\ dysplasia\\)\\.\ \(0\)\
\-\ this\\ 65\\ y\\.o\\.\\ man\\,\\ with\\ lung\\ cancer\\ \\(neuroendocrine\\ carcinoma\\ with\\ small\\ cell\\ component\\)\\ is\\ on\\ concurrent\\ radiation\\ and\\ chemotherapy\\.\ \(0\)\
\-\ hypertrophic\\ pulmonary\\ osteoarthropathy\\ \\(bamberger\\-marie\\ disease\\)\\ is\\ a\\ clinical\\ syndrome\\ of\\ clubbing\\ of\\ the\\ fingers\\ and\\ toes\\,\\ symmetric\\ periostitis\\ of\\ the\\ long\\ bones\\ of\\ the\\ upper\\ and\\ lower\\ extremities\\ and\\ painful\\ swollen\\ joints\\.\\ a\\ small\\ number\\ of\\ patients\\ have\\ primary\\ osteoarthropathy\\ so\\-called\\ pachydermoperiostosis\\ while\\ the\\ majority\\ \\(\\>\\ 95\\%\\)\\ \\ have\\ secondary\\ osteoarthropathy\\ as\\ a\\ result\\ of\\ pulmonary\\ disease\\.\ \(0\)\
\-\ \\ jajic\\ z\\,\\ jajic\\ i\\,\\ nemcic\\ t\\.\\ primary\\ hypertrophic\\ osteoarthropathy\\:\\ clinical\\,\\ radiologic\\,\\ and\\ scintigraphic\\ characteristics\\.\\ arch\\ med\\ res\\.\\ mar\\-apr\\ 2001\\;32\\(2\\)\\:136\\-42\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteoarthropathy\\:\\ 0\\.1481177503911128\ \(0\)\
\-\ jajic\\:\\ 0\\.08355941634091468\ \(0\)\
\-\ hypertrophic\\:\\ 0\\.07059768941596833\ \(0\)\
\-\ pulmonary\\:\\ 0\\.04732796796625713\ \(0\)\
\-\ 99mtechnetium\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ hpo\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ bamberger\\-marie\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ pachydermoperiostosis\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ nemcic\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ mar\\-apr\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ \\:136\\-42\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ bone\\:\\ 0\\.04025468590445251\ \(0\)\
\-\ acropachy\\:\\ 0\\.03849465044268509\ \(0\)\
\-\ succumbed\\:\\ 0\\.03415204033901611\ \(0\)\
\-\ methylene\\:\\ 0\\.03415204033901611\ \(0\)\
\-\ disease\\:\\ 0\\.03309804600037213\ \(0\)\
\-\ z\\:\\ 0\\.032557385189152535\ \(0\)\
\-\ acromegaly\\:\\ 0\\.0313663215480108\ \(0\)\
\-\ res\\:\\ 0\\.0313663215480108\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.030866982611243852\ \(0\)\
\-\ neuroendocrine\\:\\ 0\\.030866982611243852\ \(0\)\
\-\ subcarinal\\:\\ 0\\.030002899403689564\ \(0\)\
\-\ so\\-called\\:\\ 0\\.030002899403689564\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02903266147052953\ \(0\)\
\-\ periostitis\\:\\ 0\\.02863947725936833\ \(0\)\
\-\ concurrent\\:\\ 0\\.02808126382023855\ \(0\)\
\-\ t\\.\\:\\ 0\\.02808126382023855\ \(0\)\
\-\ radiation\\:\\ 0\\.02658058056457191\ \(0\)\
\-\ tracer\\:\\ 0\\.026524372507574872\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.026159628236787535\ \(0\)\
\-\ paratracheal\\:\\ 0\\.025354419531596076\ \(0\)\
\-\ clubbing\\:\\ 0\\.025067099049053732\ \(0\)\
\-\ clinical\\:\\ 0\\.024922367773137482\ \(0\)\
\-\ fingers\\:\\ 0\\.024296867155699346\ \(0\)\
\-\ toes\\:\\ 0\\.024065634150157014\ \(0\)\
\-\ primary\\:\\ 0\\.023994163629343097\ \(0\)\
\-\ lung\\:\\ 0\\.02346122388851892\ \(0\)\
\-\ apical\\:\\ 0\\.023335062207847732\ \(0\)\
\-\ med\\:\\ 0\\.02323931477980262\ \(0\)\
\-\ 95\\:\\ 0\\.02278760776651198\ \(0\)\
\-\ scan\\:\\ 0\\.022675558866663306\ \(0\)\
\-\ paget\\:\\ 0\\.02245488616142549\ \(0\)\
\-\ accumulation\\:\\ 0\\.021577433871683333\ \(0\)\
\-\ swollen\\:\\ 0\\.021577433871683333\ \(0\)\
\-\ 2001\\:\\ 0\\.021511148364694043\ \(0\)\
\-\ e\\.g\\:\\ 0\\.021445777169754064\ \(0\)\
\-\ radiologic\\:\\ 0\\.021071424509476196\ \(0\)\
\-\ \\(\\:\\ 0\\.020541091741531577\ \(0\)\
\-\ \\)\\:\\ 0\\.020290171339714835\ \(0\)\
\-\ number\\:\\ 0\\.020197353233961886\ \(0\)\
\-\ 32\\:\\ 0\\.020197353233961886\ \(0\)\
\-\ characteristics\\:\\ 0\\.020147726220372808\ \(0\)\
\-\ metabolic\\:\\ 0\\.020001888975506678\ \(0\)\
\-\ majority\\:\\ 0\\.019907099085901606\ \(0\)\
\-\ aggressive\\:\\ 0\\.019814167941880866\ \(0\)\
\-\ 65\\:\\ 0\\.01976837689490581\ \(0\)\
\-\ upper\\:\\ 0\\.019545786780746147\ \(0\)\
\-\ painful\\:\\ 0\\.019250844705498267\ \(0\)\
\-\ periosteal\\:\\ 0\\.01921016345577603\ \(0\)\
\-\ small\\:\\ 0\\.01865948136854141\ \(0\)\
\-\ joints\\:\\ 0\\.0185319604053463\ \(0\)\
\-\ component\\:\\ 0\\.018496983593509226\ \(0\)\
\-\ symmetric\\:\\ 0\\.018496983593509226\ \(0\)\
\-\ nodes\\:\\ 0\\.01829237614391108\ \(0\)\
\-\ arch\\:\\ 0\\.01822609063692179\ \(0\)\
\-\ lower\\:\\ 0\\.01821670207927832\ \(0\)\
\-\ demonstrates\\:\\ 0\\.017693091958797973\ \(0\)\
\-\ have\\:\\ 0\\.017539697425261534\ \(0\)\
\-\ continued\\:\\ 0\\.017439431217612496\ \(0\)\
\-\ bones\\:\\ 0\\.017090200337085675\ \(0\)\
\-\ nodules\\:\\ 0\\.016789188935558065\ \(0\)\
\-\ i\\:\\ 0\\.01674082793947161\ \(0\)\
\-\ thyroid\\:\\ 0\\.016598637179737967\ \(0\)\
\-\ fibrous\\:\\ 0\\.016370740560460062\ \(0\)\
\-\ lymph\\:\\ 0\\.016348542222486478\ \(0\)\
\-\ dysplasia\\:\\ 0\\.015986259305425143\ \(0\)\
\-\ vs\\:\\ 0\\.01594540270332132\ \(0\)\
\-\ extremities\\:\\ 0\\.01588477070588099\ \(0\)\
\-\ result\\:\\ 0\\.015536417805440577\ \(0\)\
\-\ extremity\\:\\ 0\\.014811179950912029\ \(0\)\
\-\ long\\:\\ 0\\.01396313512242997\ \(0\)\
\-\ enlarged\\:\\ 0\\.013818109338312828\ \(0\)\
\-\ \\>\\:\\ 0\\.013455770211699358\ \(0\)\
\-\ cancer\\:\\ 0\\.013313579451965714\ \(0\)\
\-\ \\,\\:\\ 0\\.012829860924989922\ \(0\)\
\-\ while\\:\\ 0\\.012742413459015705\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.01210439213102112\ \(0\)\
\-\ y\\.o\\:\\ 0\\.011689002050173935\ \(0\)\
\-\ his\\:\\ 0\\.011672459846667925\ \(0\)\
\-\ s\\:\\ 0\\.011615012640353493\ \(0\)\
\-\ syndrome\\:\\ 0\\.011582495624334796\ \(0\)\
\-\ weeks\\:\\ 0\\.011494207378678428\ \(0\)\
\-\ carcinoma\\:\\ 0\\.011478330189648658\ \(0\)\
\-\ secondary\\:\\ 0\\.011322416902885345\ \(0\)\
\-\ performed\\:\\ 0\\.011291840432356964\ \(0\)\
\-\ 4\\:\\ 0\\.011284227038763249\ \(0\)\
\-\ however\\:\\ 0\\.011276625855910287\ \(0\)\
\-\ cell\\:\\ 0\\.010939529438774817\ \(0\)\
\-\ therapy\\:\\ 0\\.010827681498770678\ \(0\)\
\-\ patients\\:\\ 0\\.01048139620552619\ \(0\)\
\-\ metastatic\\:\\ 0\\.010194831296758723\ \(0\)\
\-\ bilateral\\:\\ 0\\.009828520044144286\ \(0\)\
\-\ chest\\:\\ 0\\.009690658768045113\ \(0\)\
\-\ \\;\\:\\ 0\\.009599152551908028\ \(0\)\
\-\ man\\:\\ 0\\.009577876033601893\ \(0\)\
\-\ \\%\\:\\ 0\\.009447019115383924\ \(0\)\
\-\ were\\:\\ 0\\.00919566984213233\ \(0\)\
\-\ 2\\:\\ 0\\.008720874391045243\ \(0\)\
\-\ multiple\\:\\ 0\\.008529886272413597\ \(0\)\
\-\ after\\:\\ 0\\.00837915261900096\ \(0\)\
\-\ and\\:\\ 0\\.007678109249241546\ \(0\)\
\-\ a\\:\\ 0\\.007518479655328935\ \(0\)\
\-\ as\\:\\ 0\\.006125959743574065\ \(0\)\
\-\ ct\\:\\ 0\\.005664946224606839\ \(0\)\
\-\ mass\\:\\ 0\\.005632516620604572\ \(0\)\
\-\ \\:\\:\\ 0\\.0053567526824202134\ \(0\)\
\-\ is\\:\\ 0\\.005329770411229627\ \(0\)\
\-\ was\\:\\ 0\\.0046837797261312175\ \(0\)\
\-\ this\\:\\ 0\\.004555152669735228\ \(0\)\
\-\ right\\:\\ 0\\.004273136062134676\ \(0\)\
\-\ patient\\:\\ 0\\.0040596773977080005\ \(0\)\
\-\ the\\:\\ 0\\.003931259280671824\ \(0\)\
\-\ of\\:\\ 0\\.0038650550027768678\ \(0\)\
\-\ on\\:\\ 0\\.0034307630917792802\ \(0\)\
\-\ \\.\\:\\ 0\\.002187175209789107\ \(0\)\
\-\ to\\:\\ 0\\.0020240194712937737\ \(0\)\
\-\ with\\:\\ 0\\.0016635664846903753\ \(0\)\
